Sotera Health Co Earnings Per Share Disclosure
| Year Ended December 31, | |||||||||||||||||
| in thousands of U.S. dollars and share amounts (except per share amounts) | 2025 | 2024 | 2023 | ||||||||||||||
| Earnings: | |||||||||||||||||
| Net income | $ | 77,949 | $ | 44,398 | $ | 51,376 | |||||||||||
| Less: Allocation to participating securities | 4 | 59 | 287 | ||||||||||||||
| Net income attributable to Sotera Health Company common stockholders | $ | 77,945 | $ | 44,339 | $ | 51,089 | |||||||||||
| Weighted Average Common Shares: | |||||||||||||||||
| Weighted-average common shares outstanding - basic | 283,956 | 282,784 | 281,008 | ||||||||||||||
| Dilutive effect of potential common shares | 2,465 | 2,122 | 2,213 | ||||||||||||||
| Weighted-average common shares outstanding - diluted | 286,421 | 284,906 | 283,222 | ||||||||||||||
| Earnings per Common Share: | |||||||||||||||||
| Net income per common share attributable to Sotera Health Company common stockholders - basic | $ | 0.27 | $ | 0.16 | $ | 0.18 | |||||||||||
| Net income per common share attributable to Sotera Health Company common stockholders - diluted | 0.27 | 0.16 | 0.18 | ||||||||||||||
| Year Ended December 31, | |||||||||||||||||
| in thousands of share amounts | 2025 | 2024 | 2023 | ||||||||||||||
| RSUs | 9 | 34 | 291 | ||||||||||||||
| Stock options | 5,550 | 5,469 | 4,108 | ||||||||||||||
| Total anti-dilutive securities | 5,559 | 5,503 | 4,399 | ||||||||||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.